Cromwell Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.78M Sell
2,405
-208
-8% -$245K 1.26% 15
2026
Q2
$3.13M Buy
2,613
+275
+12% +$281K 1.41% 13
2026
Q1
$2.15M Hold
2,338
– – 1.21% 12
2025
Q4
$2.51M Hold
2,338
– – 1.37% 12
2025
Q3
$1.78M Hold
2,338
– – 0.95% 14
2025
Q2
$1.82M Hold
2,338
– – 1.11% 13
2025
Q1
$1.93M Hold
2,338
– – 1.24% 13
2024
Q4
$1.8M Hold
2,338
– – 1.04% 16
2024
Q3
$2.07M Hold
2,338
– – 1.33% 10
2024
Q2
$2.12M Buy
+2,338
New +$1.87M 1.27% 11

Other funds holding LLY

Cromwell Holdings's LLY Position: Q3 2026 in Review

Cromwell Holdings reduced its Eli Lilly (LLY) stake by 8% in Q3 2026, selling an estimated $245K and leaving 2,405 shares worth $2.78M. The position accounts for 1.26% of the portfolio, ranked #15.

Cromwell Holdings first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $3.13M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cromwell Holdings held 2,405 shares of Eli Lilly worth $2.78M as of Q3 2026.
  • Cromwell Holdings sold 208 Eli Lilly shares in Q3 2026, an estimated $245K.
  • Eli Lilly made up 1.26% of Cromwell Holdings's portfolio in Q3 2026, its #15 holding.
  • Cromwell Holdings first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • Cromwell Holdings's Eli Lilly position peaked at $3.13M in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.